Hyperammonemia From Ureaplasma Infection in an Immunocompromised Child.
J Pediatr Hematol Oncol
; 42(2): e114-e116, 2020 03.
Article
en En
| MEDLINE
| ID: mdl-30789458
Idiopathic hyperammonemia is a rare, poorly understood, and often lethal condition that has been described in immunocompromised patients. This report describes an immunocompromised patient with acute myelogenous leukemia who developed persistent hyperammonemia up to 705 µmol/L (normal, 0 to 47 µmol/L) refractory to multiple different therapies. However, after beginning azithromycin and then doxycycline therapy for Ureaplasma species infection, the patient showed immediate and sustained clinical improvement and resolution of ammonia levels. Recognizing disseminated Ureaplasma species infection as a potential cause of idiopathic hyperammonemia, an unexplained, often fatal condition in immunocompromised patients, and empirically treating for this infection could potentially be lifesaving.
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Ureaplasma
/
Leucemia Mieloide Aguda
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Infecciones por Ureaplasma
/
Huésped Inmunocomprometido
/
Hiperamonemia
/
Quimioterapia de Inducción
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
J Pediatr Hematol Oncol
Asunto de la revista:
HEMATOLOGIA
/
NEOPLASIAS
/
PEDIATRIA
Año:
2020
Tipo del documento:
Article